Organization and Description of Business - Additional Information (Details) - USD ($) $ in Thousands |
Apr. 14, 2025 |
Nov. 15, 2023 |
Nov. 14, 2023 |
Jun. 30, 2025 |
Dec. 31, 2024 |
Jun. 30, 2024 |
|---|---|---|---|---|---|---|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||||
| Cash and cash equivalents | $ 77,094 | $ 115,462 | $ 121,587 | |||
| Discontinue of Clinical Development | ||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||||
| Percentage of positions reduced | 90.00% | |||||
| Alkermes | ||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||||
| Effective time of distribution | Nov. 15, 2023 | |||||
| Cash distribution received from parent | $ 275,000 | |||||
| Distribution term of shares | one ordinary share of the Company for every ten ordinary shares |